FDA, EMA grant BIOX-101 ODD status to treat intracerebral hemorrhagic stroke (ICH)ODD status may expedite drug candidate development and approvals BIOX-101 interim Phase 2a data in ICH imminent ...

Learn the seven critical warning signs of a stroke, from sudden numbness to vision problems, and why immediate action is ...

Nasal decongestants, often used during cold and allergy seasons, can negatively impact brain health when used long-term or in ...

PRESTIGE-AF is the first of the larger trials in this scenario to report results. More data are needed to help guide ...

For every hour without treatment after a stroke, the brain loses as many neurons as it typically does in nearly 3.6 years of ...

Medtronic also recently teamed with Tempus to assess the use of artificial intelligence to identify people eligible for ...

For more than a century, strokes have been a leading cause of death among U.S. adults, according to the Centers for Disease ...